Back to search

Netherlands· NL-586619dff2a7

Duodopa 240 mg/ml + 12 mg/ml oplossing voor infusie

A foslevodopa und decarboxylasehemmer product containing foscarbidopa x-water + foslevodopa, registered in Netherlands by AbbVie B.V.. The same ATC class is registered in 8 of our 19 countries.

ATC N04BA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDuodopa 240 mg/ml + 12 mg/ml oplossin…ATCN04BA07REGISTER NO.NL-586619dff2a7PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Foslevodopa und decarboxylasehemmer is registered in 8 of 19 countries.

Countries holding a registration under ATC N04BA07 (foslevodopa und decarboxylasehemmer), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Foslevodopa und decarboxylasehemmer · ATC N04BA07

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FOSCARBIDOPA X-WATER + FOSLEVODOPA
Manufacturer
AbbVie B.V.
Country
Netherlands (NL)
ATC code
N04BA07
ATC class
Foslevodopa und Decarboxylasehemmer
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128752

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Foslevodopa und decarboxylasehemmer in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All foslevodopa und decarboxylasehemmer products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Produodopa
  • Belgium · Produodopa
  • Bulgaria · Продуодопа
  • Cyprus · Produodopa
  • Czechia · Duodopa Sc
  • Germany · Produodopa®
  • Denmark · Duodopa
  • Estonia · Produodopa
  • Spain · Duodopa
  • Finland · Produodopa
  • France · Scyova
  • Greece · Produodopa
  • Croatia · Produodopa
  • Hungary · Produodopa
  • Ireland · Produodopa
  • Iceland · Produodopa
  • Italy · Duodopa
  • Liechtenstein · Produodopa
  • Lithuania · Duodopa
  • Luxembourg · Produodopa
  • Norway · Produodopa
  • Poland · Produodopa
  • Portugal · Duodopa
  • Romania · Produodopa
  • Sweden · Produodopa
  • Slovenia · Produodopa
  • Slovakia · Duodopa Sc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/93331cf1-7b6d-4bef-86b9-9be6d077fe1a
GET /v1/drugs/93331cf1-7b6d-4bef-86b9-9be6d077fe1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128752_smpc.pdf",
  "strength": null,
  "atc_label": "Foslevodopa and Decarboxylase Inhibitor",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128752",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FOSCARBIDOPA X-WATER",
    "FOSLEVODOPA"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128752.pdf",
  "authorised_at": "2022/11/07",
  "procedure_number": "SE/H/0415/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128752",
  "additional_monitoring": "N"
}

See everything about foslevodopa und decarboxylasehemmer.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.